M R MANIVENI FOODS LIMITED
	(Corporate Identity Number: U15313TN2010PLC076382)
	Our Company was original incorporated on June 30, 2010 under the name "K.R.M. Ramadevi Enterprises Private Limited" under the provisions of the Companies Act, 1956 and the Certificate of Incorporation was issued by the Deputy Registrar of Companies, Tamil Nadu, Chennai, Andaman and Nicobar Islands, bearing Corporate Identity Number (CIN) U15313TN2010PTC076382. Pursuant to a special resolution passed by our members in Extra-Ordinary General Meeting dated April 29, 2021, the name of the Company was changed to 'M. Ramadevi Enterprises Private Limited' and a fresh certificate of incorporation dated May 13, 2021 was issued to our Company by the Registrar of Companies, Chennai. Thereafter, pursuant to a special resolution passed by our Shareholders in the Extra-ordinary General Meeting held on January 25, 2025, the name of our Company was changed to 'M R Maniveni Foods Private Limited' and a fresh certificate of incorporation dated February 10, 2025 was issued to our Company by the Registrar of Companies, Central Processing Centre, bearing CIN U15313TN2010PTC076382 Pursuant to special resolution passed by our Shareholders in the Extra-Ordinary General Meeting held on February 11, 2025, our Company was converted from a private limited company to public limited company and consequently, the name of our Company was changed to 'M R Maniveni Foods Limited' and a fresh certificate of incorporation dated February 24, 2025 was issued to our Company by the Registrar of Companies, Central Processing Centre. The present CIN of our Company is U15313TN2010PLC076382.
	Registered Office: S.No.220/3A-3B, Madhavaram-Redhills High Road (Near Vadaperumbakkam), Madhavaram, Chennai, Tamil Nadu, India, 600060. Website: www.mrgolddhall.com; E-Mail: admin@mrgolddhall.com; Telephone No: +91-9840777269; Company Secretary and Compliance Officer: Krishnamachari Ramu

1. Our Company had received share application money in cash for certain past allotments, for which bank statements are not available, and any non-compliance or regulatory action in this regard may adversely affect our Company.

2. We have long-standing relationships with our suppliers However, we have not entered into any long-term contracts with suppliers for our black gram and raw pigeon pea and an increase in the cost or a shortfall in the availability of such black gram and raw pigeon pea or our inability to leverage existing or new relationships with our suppliers could have an adverse effect on our business and results of operations.

3. We have long-standing relationships with our customers However, our Company, in the usual course of business does not have any long-term contracts with its customers and we rely on purchase orders for delivery of our products. Any cancellation, modification, and postponement of our orders could materially harm our cash flow position, revenues and earnings.

4. We have obtained the Consent to Establish ("CTE") for our proposed fully automated Toor Dal processing plant Any delay in obtaining subsequent consents, Consent to Operate ("CTO"), or failure to comply with applicable environmental and regulatory conditions approval which may adversely affect our operations, expansion plans, and financial performance.

5. We are highly dependent on our existing milling facility located in Thiruvallur, Tamil Nadu, and any slowdown, interruption, shutdown or under-utilization of the facility may adversely affect our business, financial conation and results of operations.

6. We are significantly dependent on the sale of Toor Dal and Urad Dal, and any decline in demand for these products could adversely impact our business, financial condition, results of operations and cash flows.

7. In the past, there have been discrepancies in fillings with the Registrar of Companies (RoC) and other non-compliances under the Companies Act , which may result in penalties.

8. Our operations are highly dependent on the uninterrupted supply of black gram and raw pigeon pea, primarily Toor dal and Urad dal. Any shortage, delay, disruption in supply, or significant volatility in their prices may materially and adversely affect our manufacturing operations, profitability, working capital requirements, and overall financial condition.

9. We have experienced negative cash flows in the past. Any negative cash flows in the future would adversely affect our cash flow requirements, which may adversely affect our ability to operate our business and implement our growth plans, thereby affecting our financial condition.

10. There have been instances of delayed filings in the past with certain Regulatory Authorities. If the Regulatory Authorities impose any monitory penalties on us or take any punitive actions against our Company in relation to the same, our business, financial condition and results of operations could be adversely affected.

1. Basic & Diluted Earnings per share (EPS)

2. Return on Net Worth

3. Net Asset Value (NAV) per Equity Share

4. Price to Earnings (P/E) ratio in relation to Price Band of Rs.51 and Rs.52 per Equity Shares of Face Value of RS.10/-each fully paid up

5. Comparison of Accounting Ratios with Industry Peers

6. Weighted average cost of acquisition, floor price and cap price:

The Issue is being made through the Book Building Process, in terms of Rule 19(2)(b)(i) of the Securities Contracts (Regulation) Rules, 1957, as amended ("SCRR") read with Regulation 229(2) of the SEBIICDR Regulations, and in compliance with Regulation 253 of the SEBIICDR Regulations, as amended, wherein not more than 50% of the Net Issue shall be allocated on a proportionate basis to Qualified Institutional Buyers ("QIBs", the 'QIB Portion'), provided that our Company may, in consultation with the Book Running lead Managers, allocate up to 60% of the QIB Portion to Anchor Investors on a discretionary basis in accordance with the SEBIICDR Regulations ("Anchor Investor Portion"), of which 40% of the anchor investor portion, shall be reserved as under (i) 33.33 per cent for domestic mutual funds; and (i) 6.67 per cent for life insurance companies and pension funds; Any under subscription in the reserved category specified in clause (ii) above may be allocated to domestic mutual funds. In the event of under-subscription. or non-allocation in the Anchor Investor Portion, the balance Equity Shares shall be added to the Net QIB Portion. Further, 5% of the Net QIB Portion shall be available for allocation on a proportionate basis only to Mutual Funds, and the remainder of the Net QIB Portion shall be available for allocation on a proportionate basis to all QIBs, including Mutual Funds, subject to valid Bids being received at or above the Issue Price. However, if the aggregate demand from Mutual Funds is less than 5% of the Net QI8 Portion, the balance Equity Shares available for allocation in the Mutual Fund Portion will be added to the remaining Net QIB Portion for proportionate allocation to QIBs. Further, not less than 15% of the Net Issue shad be available for allocation on a proportionate basis to Non-Institutional Investors, out of which (a) one third of such portion was reserved for applicants with application size of more than 2 lots and up to such lots equivalent to not more than RS. 10 lakhs and (b) two-third of such portion was reserved for applicants with application size of more than RS. 10 lakhs provided that the unsubscribed portion in either of such subcategories could have been allocated to applicants in the other sub-category of Non-Institutional Bidders and not less than 35% of the Net Issue shall be available for allocation to Individual Bidders in accordance with the SEBIICDR Regulations, subject to valid Bids being received at or above the Issue Price. All potential Bidders (except Anchor Investors) are required to mandatory utilize the Application Supported by Blocked Amount ("ASBA") process providing details of their respective ASBA accounts, and UPI ID in case of IBs using the UPI Mechanism, if applicable, in which the corresponding Bid Amounts will be blocked by the SCSBs or by the Sponsor Bank under the UPI Mechanism, as the case may be, to the extent of respective Bid Amounts. Anchor Investors are not permitted to participate in the Issue through the ASBA process. For details, see "Issue Procedure" beginning on page 265 of the Prospectus. The Investor are advised to refer to the prospectus for full text of Disclaimer clause pertaining to BSE for the purpose of this issue the designated stock exchange will be the BSE Limited ("BSE-SME") the trading is proposed to be commenced on June 01, 2026*

The Issue is being made through the Book Building Process as per Regulation 229(2) and Regulation 253 of the SEBIICDR Regulators. For further detail refer Chapter title "Issue Structure" beginning on page 260 of the Prospectus The bidding for Anchor Investor is opened and closed on Thursday, May 21, 2026. The company has received application from 2 Anchors investor application for 14,70,000 shares. The Anchor investor allocation price was finalized at Rs. 52/- per equity share. A total of 14,70,000 were allotted under Anchor investor portion aggregating to Rs. 7,64,40,000.

The Issue (Including Anchor Investors Portion) received 968 Applications for 77,08,000 Equity Shares (prior to rejections) resulting in 1.48 times subscription (including reserved portion of market maker). The details of the Applications received in the Issue from various categories are as under:

The Basis of Allotment to the individual Investors, who have Bid at cut-off Price or at or above the Issue Price of Rs. 52/- per Equity Share, was finalized in consultation with SME Platform of BSE Limited. The category was subscribed by 2.06 times i.e., for 35,72,000 Equity Shares. The total number of Equity Shares allotted in this category is 17,32,000 Equity Shares to 893 successful applicants.

The category wise details of the Basis of Allotment are as under:

The Basis of Allotment to Non-Institutional Investors, who have bid at cut off or at the Issue price of Rs. 52 per Equity Share, was finalized in consultation with SME Platform of BSE Limited. The category was subscribed by 1.46 times i.e., for 3,68,000 Equity Shares. The total number of shares allotted in the category is 2,52,000 Equity Shares to 31 successful applicants.

The Basis of Allotment to Non-Institutional Investors, who have hid at cut off or at the Issue price of Rs. 52 per Equity Share, was finalized in consultation with SME Platform of BSE Limited. The category was subscribed by 2.10 times i.e., for 10,56,000 Equity Shares. The total number of shares allotted in this category is 5,04,000 Equity Shares to 39 successful applicants.

The Company in consultation with BRLM has allocated 14,70,000 Shares to 2 Anchor Investors at the Anchor Investor Issue Price of Rs. 52 per Equity Share in accordance with the SEBI (ICDR) Regulations. The category wise details of the Basis of Allotment are as under:

The Basis of Allotment to Qualified Institutional Buyers, at the Issue price of Rs. 52 per Equity Share, was finalized in consultation with SME Platform of BSE Limited. The category was subscribed by 1 times i.e., for 9,82,000 Equity Shares. The total number of shares allotted in this category is 9,82,000 Equity Shares to 2 successful applicants.

The Basis of Allotment to the Market Maker, at the Issue price of Rs. 52 per Equity Share, was finalized in consultation with SME Platform of BSE Limited. The category was subscribed 1 time i.e., for 2,60,000 Equity Shares. The total number of shares allotted in this category is 2,60,000 Equity Shares to 1 successful applicant.

The Board of the Directors of our Company at its meeting held on Wednesday, May 27, 2026. has taken on record the basis of allotment of Equity Shares approved by the Designated Stock Exchange, being SME Platform of BSE Limited and has allotted the Equity Shares to various successful applicants. The Allotment Advice Cum Refund Intimation will be dispatched to the address of the investors as registered with the depositories. Further, instructions to the SCSBs have been dispatched/mailed for unblocking of funds and transfer to the Pubic Issue Account on or about Wednesday, May 27, 2026. In case the same is not received within ten days, investors may contact the Registrar to the Issue at the address given below. The Equity Shares allocated to successful applicants are being credited to their beneficiary accounts subject to validation of the account details with the depositories concerned. The Company is in process of obtaining the listing and trading approval from SME Platform of BSE Limited and the trading of the Equity Shares is expected to commence on or about Monday, June 01, 2026.

Note: All capitalized terms used and not defined herein shall have the respective meanings assigned to them in the Prospectus dated May 27, 2026 filed with the ROC, Assistant Registrar of Companies/ Deputy Registrar of Companies/Registrar of Companies, Central Processing Centre on Wednesday, May 27, 2026.

The details of the allotment made has been hosted on the website of the Registrar to the Issue, Bigshare Services Private Limited at website: www.bigshareonline.com future correspondence in this regard may kindly be addressed to the Registrar to the Issue quoting full name of the First/ Sole Bidder Serial number of the ASBA form, number of Equity Shares bid for, Bidder DP ID, Client ID, PAN, date of submission of the Bid cum Application Form, address of the Bidder, the name and address of the Designated Intermediary where he Bid cum Application Form was submitted by the Bidder and copy of the Acknowledgment Slip received from the Designated intermediaries and payment details at the address given below:

BOOK RUNNING LEAD MANAGER TO THE ISSUE	REGISTRAR TO THE ISSUE
CAPITALSQUARE ADVISORS PRIVATE LIMITED	Bigshare Services Private Limited
Address: 208 Aarpee Centre, MIDC Road No. 11 CTS - 70. Andheri (E), Mumbai, Maharashtra, India, 400093	Address: Office No S6-2, 6th floor Pinnacle Business Park, Next to Ahura Centre, Mahakali Caves Road, Andheri (East) Mumbai - 400093
Telephone: 022-6684 9999/022-6684 9946; E-mail: mb@capitalsquare.in; Website: www.capitalsquare.in; Investor Grievance Email-Id: investor.grievance@capitalsquare.in	Tel. No: +91 22-6263-8200; Email Id: ipo@bigshareonline.com; Website: www.bigshareonline.com
Contact Person: Nikhil Joshi/ Sandesh Jha /Neel Bhadra; CIN: U65999MH2008PTC187863; SEBI Registration Number: INM000012219	Contact Person: Vinayak Morbale; SEBI Registration No.: INR000001385; CIN: U99999MH1994PTC076534

Disclaimer: M R Maniveni Foods Limited has filed a Prospectus dated May 27, 2026 with the Registrar of Companies. The Prospectus shall be made available on the website of the SEBI at www.sebi.gov.in as well as on the website of the BRLM i.e., Capitalsquare Advisors Private Limited at www.capitalsquare.in, the website of the BSE at www.bsesme.com and the website of the Issuer Company at www.mrgolddhall.com. Any potential investor should note that investment in equity shares involves a high degree of risk and for details relating to such risks, see "Risk Factors" on page 24 of the Prospectus.

The Equity Shares issued in the Issue have not been and will not be registered under tie U.S. Securities Act of 1933, as amended (the "Securities Act") or any state securities laws in the United States and may not be offered or sold within the United Stales or to, or for the accord or benefit of U.S. persons* (as defined in Regulation of the Securities Act), except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. Accordingly, the Equity Shares will be offered and sold (i) within the United States only to persons reasonably believed to be "Qualified Institutional Buyers" (as defined in Rule 144A of the Securities Act) under Section 4(a) of the Securities Act and (ii) outside the United States in offshore transaction in reliance on Regulations under the Securities Act and the applicable laws of the jurisdiction where those offer and sales occur. The Equity Shares have not been and will not be registered, listed or otherwise qualified in any other jurisdiction outside India and may not be offered or sold, and Application may not be made by persons in any such jurisdiction, expect in compliance with the applicable laws of such jurisdiction.